InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Powell Lynne, Director. Director active across 3 companies, notably PROGENITY, INC.. Cumulatively, 6 reports have been published. Activity tracked since 14 June 2021. The latest transaction was filed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Lynne Powell is a Board Member at PROGENITY, INC. and BIORA THERAPEUTICS, INC. She contributes to the governance of the companies, bringing her expertise in the biotechnology sector. Her role on the boards is essential for strategic development.